SIGNIFICANT ACCOUNTING POLICIES AND OTHER RISKS AND UNCERTAINTIES (Tables)
|
6 Months Ended |
Sep. 30, 2026 |
| Accounting Policies [Abstract] |
|
| SCHEDULE OF DISPOSAL OF ASSETS AND LIABILITIES |
SCHEDULE OF DISPOSAL OF ASSETS AND LIABILITIES
| (in thousands) | |
September 30, 2026 | |
| Cash and cash equivalents | |
$ | 2,656 | |
| Other current assets | |
| 352 | |
| Total current assets | |
$ | 3,008 | |
| | |
| | |
| Property and equipment, net | |
| 3 | |
| Other assets | |
| 13 | |
| Total assets | |
$ | 3,024 | |
| | |
| | |
| Accounts payable | |
| 672 | |
| Accrued expenses | |
| 87 | |
| Total current liabilities | |
$ | 759 | |
|
| SCHEDULE OF FAIR VALUE ON A RECURRING BASIS |
The
following table presents the Company’s assets and liabilities that are measured at fair value on a recurring basis:
SCHEDULE OF FAIR VALUE ON A RECURRING BASIS
The
fair value amounts as of September 30, 2026 are:
| (in thousands) | |
Total | | |
Level 1 | | |
Level 2 | | |
Level 3 | |
| | |
| | |
| | |
| | |
| |
| Marketable securities: | |
| | | |
| | | |
| | | |
| | |
| Fixed income securities | |
$ | 5,652 | | |
$ | 5,652 | | |
$ | - | | |
$ | - | |
| Total assets measured and recorded at fair value | |
$ | 5,652 | | |
$ | 5,652 | | |
$ | - | | |
$ | - | |
| | |
| | | |
| | | |
| | | |
| | |
| Liabilities: | |
| | | |
| | | |
| | | |
| | |
| Warrant liability | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
| Total liabilities measured and recorded at fair value | |
$ | - | | |
$ | - | | |
$ | - | | |
$ | - | |
The
fair value amounts as of March 31, 2026 are:
| (in thousands) | |
Total | | |
Level 1 | | |
Level 2 | | |
Level 3 | |
| | |
| | |
| | |
| | |
| |
| Marketable securities: | |
| | | |
| | | |
| | | |
| | |
| Fixed income securities | |
$ | 4,901 | | |
$ | 4,901 | | |
$ | - | | |
$ | - | |
| Total assets measured and recorded at fair value | |
$ | 4,901 | | |
$ | 4,901 | | |
$ | - | | |
$ | - | |
| | |
| | | |
| | | |
| | | |
| | |
| Liabilities: | |
| | | |
| | | |
| | | |
| | |
| Warrant liability | |
$ | 2 | | |
$ | - | | |
$ | - | | |
$ | 2 | |
| Total liabilities measured and recorded at fair value | |
$ | 2 | | |
$ | - | | |
$ | - | | |
$ | 2 | |
|
| SUMMARY OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED GAINS AND LOSSES |
The
following table summarizes the Company’s short-term marketable securities with unrealized gains and losses as of September 30,
2026, aggregated by major security type:
SUMMARY OF SHORT-TERM MARKETABLE SECURITIES WITH UNREALIZED GAINS AND LOSSES
| (in thousands) | |
Fair Value | | |
Unrealized Gains | |
| Fixed income securities | |
$ | 5,652 | | |
$ | 60 | |
| Total short-term marketable securities | |
$ | 5,652 | | |
$ | 60 | |
The
following table summarizes the Company’s short-term marketable securities with unrealized gains and losses as of March 31, 2026,
aggregated by major security type:
| (in thousands) | |
Fair Value | | |
Unrealized Gains | |
| Fixed income securities | |
$ | 4,901 | | |
$ | 39 | |
| Total short-term marketable securities | |
$ | 4,901 | | |
$ | 39 | |
|
| SCHEDULE OF ASSUMPTIONS USED IN VALUING WARRANTS |
The
significant assumptions used in valuing the warrants were as follows:
SCHEDULE OF ASSUMPTIONS USED IN VALUING WARRANTS
| At September 30, 2026 | |
Warrants | |
| Expected term (in years) | |
| 1.75 | |
| Volatility | |
| 131.28 | % |
| Risk-free rate | |
| 4.8 | % |
| At March 31, 2026 | |
Warrants | |
| Expected term (in years) | |
| 2.25 | |
| Volatility | |
| 132.1 | % |
| Risk-free rate | |
| 3.8 | % |
|
| SCHEDULE OF CHANGES IN FAIR VALUE OF WARRANTS |
The
table presented below is a summary of changes in the fair value of the Company’s Level 3 valuation for the warrants for the six
months ended September 30, 2026 (in thousands):
SCHEDULE OF CHANGES IN FAIR VALUE OF WARRANTS
| | |
Warrants | |
| Balance at March 31, 2026 | |
$ | 2 | |
| Change in fair value | |
| (2 | ) |
| Balance at September 30, 2026 | |
$ | - | |
|
| SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH |
The
following table is the reconciliation of the presentation and disclosure of cash, cash equivalents, marketable securities by major security
type, and restricted cash as shown on the Company’s condensed consolidated statements of cash flows:
SCHEDULE OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH
| (in thousands) | |
September 30, 2026 | | |
March 31, 2026 | |
| Cash and cash equivalents | |
$ | 5,397 | | |
$ | 6,740 | |
| Cash and cash equivalents, held for sale | |
| 2,656 | | |
| - | |
| Restricted cash | |
| 4,832 | | |
| 5,622 | |
| Total cash, cash equivalents and restricted cash | |
$ | 12,885 | | |
$ | 12,362 | |
| Marketable securities: | |
| | | |
| | |
| Fixed income securities | |
| 5,652 | | |
| 4,901 | |
| Total marketable securities | |
$ | 5,652 | | |
$ | 4,901 | |
| | |
| | | |
| | |
| Total cash, cash equivalents, marketable securities and restricted cash | |
$ | 18,537 | | |
$ | 17,263 | |
|